iso-sulfan blue has been researched along with Local Neoplasm Recurrence in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kitagawa, Y; Matsuda, T; Mukai, M; Nakahara, T; Takeuchi, H; Tsuwano, S | 1 |
| Anderson, SJ; Ashikaga, T; Brown, AM; Costantino, JP; Frazier, TG; Harlow, SP; Jalovec, LM; Julian, TB; Krag, DN; Mamounas, EP; Noyes, RD; Robidoux, A; Scarth, HM; Weaver, DL; Wolmark, N | 1 |
| Casey, WJ; Gray, RJ; Jensen, JD; Kreymerman, P; Pockaj, BA; Roarke, MC; Wasif, N | 1 |
| Collins, JC; DiFronzo, LA; Giuliano, AE; Grube, BL; Guenther, JM; Hansen, NM; O'Connell, TX | 1 |
| Blanchard, DK; Donohue, JH; Grant, CS; Reynolds, C | 1 |
| Cruse, CW; Pu, LL; Reintgen, DS; Shons, AR; Wells, KE | 1 |
| Burke, TW; Eifel, P; Frumovitz, M; Levenback, C; Malpica, A; Ramirez, PT; Tortolero-Luna, G | 1 |
| Bilchik, AJ; Chen, SL; DiNome, M; Elashoff, D; Gonzalez, M; Hoon, DS; Iddings, D; Koyanagi, K; McCarter, M; Morton, DL; Saha, S; Shen, P; Turner, RR; Wiese, D | 1 |
| Beechey-Newman, N | 1 |
1 review(s) available for iso-sulfan blue and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Sentinel node biopsy: a revolution in the surgical management of breast cancer?
Topics: Axilla; Biopsy; Breast Neoplasms; Carcinoma; Female; Humans; Lymph Node Excision; Lymph Nodes; Melanoma; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Rosaniline Dyes; Skin Neoplasms; Survival Rate; Tomography, Emission-Computed | 1998 |
2 trial(s) available for iso-sulfan blue and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.
Topics: Axilla; Breast Neoplasms; Canada; Chemotherapy, Adjuvant; Coloring Agents; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Lymph Node Excision; Lymphatic Metastasis; Mastectomy, Modified Radical; Mastectomy, Segmental; Middle Aged; Neoplasm Recurrence, Local; Proportional Hazards Models; Radiopharmaceuticals; Radiotherapy, Adjuvant; Risk Assessment; Risk Factors; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Technetium Tc 99m Sulfur Colloid; Time Factors; Treatment Outcome; United States | 2010 |
Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial.
Topics: Aged; Colectomy; Colonic Neoplasms; Coloring Agents; Disease-Free Survival; Female; Fluorescent Dyes; Follow-Up Studies; Humans; Immunohistochemistry; Keratins; Lymphatic Metastasis; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Prospective Studies; Rectal Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Survival Rate | 2007 |
6 other study(ies) available for iso-sulfan blue and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Sentinel node mapping in adenocarcinoma of the esophagogastric junction.
Topics: Adenocarcinoma; Aged; Coloring Agents; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Feasibility Studies; Female; Humans; Indocyanine Green; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Rosaniline Dyes; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Technetium Compounds; Tin Compounds | 2014 |
Can lymphatic drainage of head and neck melanoma be predicted?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Coloring Agents; Female; Head and Neck Neoplasms; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Skin Neoplasms; Technetium Tc 99m Sulfur Colloid; Tomography, Emission-Computed, Single-Photon; Young Adult | 2011 |
Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Cohort Studies; Female; Humans; Lymph Node Excision; Lymphatic Metastasis; Mastectomy; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Receptors, Estrogen; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2003 |
Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer.
Topics: Aged; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Female; Humans; Immunohistochemistry; Logistic Models; Lymph Node Excision; Lymphatic Metastasis; Lymphedema; Middle Aged; Morbidity; Neoplasm Recurrence, Local; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2003 |
Prevalence of additional positive lymph nodes in complete lymphadenectomy specimens after positive sentinel lymphadenectomy findings for early-stage melanoma of the head and neck.
Topics: Adult; Aged; Axilla; Female; Head and Neck Neoplasms; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neck Dissection; Neoplasm Recurrence, Local; Radionuclide Imaging; Retrospective Studies; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2003 |
Characteristics of recurrence in patients who underwent lymphatic mapping for vulvar cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Lymph Node Excision; Lymph Nodes; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Vulvar Neoplasms | 2004 |